review glp 1 GLP-1 receptor agonists effective for obesity and liver disease treatment Glucagon-like peptide-1 receptor: mechanisms and

NICE recommends a target of 48 mmol/mol (6.5%) for most adults with type 2 diabetes not taking medications that cause hypoglycaemia, and 53 mmol/mol (7.0%) for those on insulin or sulfonylureas

The less common but more serious possibilities (pancreatitis symptoms, severe allergic reaction, significant heart rate changes) require immediate medical attention

The Eating Disorder Examination: Reliability and validity of the Italian version

These categories reflect a clinical focus on patients with the greatest metabolic and cardiovascular benefit potential, rather than universal weightloss coverage

Mary Claire Haver is a board-certified OB-GYN and certified menopause practitioner

The Care Pharmacy is a GPhC-registered UK pharmacy offering Mounjaro and Wegovy through a fully regulated online consultation